Kenneth Kassler-Taub

Comparative Efficacy of Two Angiotensin II Receptor Antagonists, Irbesartan and Losartan, in Mild-to-Moderate Hypertension

Kenneth Kassler-Taub · American Journal of Hypertension · 1998 · 168 citations · Full text

Hypertension, Angiotensin Ii, Cardiovascular Disease +12

Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial

Marianne Pavel, David J. Gross, Marta Benavent et al. · Endocrine Related Cancer · 2018 · 135 citations · Full text

Comparative glycemic control, safety and patient ratings for a new 4 mm <b>×</b> 32G insulin pen needle in adults with diabetes

Laurence Hirsch, Michael A. Gibney, John Albanese et al. · Current Medical Research and Opinion · 2010 · 104 citations

Dose-Related Efficacy of Irbesartan for Hypertension

Richard A. Reeves, Chensheng Lin, Kenneth Kassler-Taub et al. · Hypertension · 1998 · 88 citations

A randomised, double-blind comparison of the angiotensin II receptor antagonist, irbesartan, with the full dose range of enalapril for the treatment of mild-to-moderate hypertension

A Mimran, Luís M. Ruilope, Linda Kerwin et al. · Journal of Human Hypertension · 1998 · 87 citations

Hypertension, Cardiovascular Disease, Antihypertensive Agents +9